Literature DB >> 25369438

Neurologic complications of systemic lupus erythematosus, sjögren syndrome, and rheumatoid arthritis.

Shamik Bhattacharyya1, Simon M Helfgott2.   

Abstract

Neurologic complications are frequent and often morbid in systemic lupus erythematosus, Sjögren syndrome, and rheumatoid arthritis. Although all are systemic inflammatory syndromes, each disease affects the nervous system distinctly, such as peripheral neuropathy in Sjögren syndrome, cerebrovascular disease in lupus, and cervical spine subluxation in rheumatoid arthritis. Some neurologic complications share convergent pathophysiology across diseases, such as neuromyelitis optica spectrum disorders in both Sjögren syndrome and lupus. Ill-defined cognitive complaints are especially common in lupus and Sjögren syndrome. For the majority of the complications, evidence for treatment efficacy is limited and requires further investigation. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 25369438     DOI: 10.1055/s-0034-1390391

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  10 in total

Review 1.  Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.

Authors:  Luis Querol; Jérôme Devaux; Ricard Rojas-Garcia; Isabel Illa
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

2.  Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.

Authors:  Dawn L Hershman; Cathee Till; Jason D Wright; Danielle Awad; Scott D Ramsey; William E Barlow; Lori M Minasian; Joseph Unger
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

Review 3.  Oral burning: local and systemic connection for a patient-centric approach.

Authors:  Jaisri Thoppay; Bhavik Desai
Journal:  EPMA J       Date:  2019-01-14       Impact factor: 6.543

4.  Epstein - Barr virus Infection in a Patient with Neuromyelitis Optica Spectrum Disorder and Sjögren's Syndrome: A Case Report and Review of Literature.

Authors:  Justin B Levinson; Milena Rodriguez Alvarez; Kristaq Koci; Aleksander Feoktistov; Isabel M McFarlane
Journal:  Clin Case Rep Rev       Date:  2018-05-31

5.  Persistent neuropathy among early-stage breast cancer survivors in a population-based cohort.

Authors:  Kristina Engvall; Henrik Gréen; Mats Fredriksson; Elisabeth Åvall-Lundqvist
Journal:  Br J Cancer       Date:  2021-05-20       Impact factor: 7.640

Review 6.  Pathways leading to an immunological disease: systemic lupus erythematosus.

Authors:  Olga Zharkova; Teja Celhar; Petra D Cravens; Anne B Satterthwaite; Anna-Marie Fairhurst; Laurie S Davis
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

7.  Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.

Authors:  Pietro Maggi; Martina Absinta; Matteo Grammatico; Luisa Vuolo; Giacomo Emmi; Giovanna Carlucci; Gregorio Spagni; Alessandro Barilaro; Anna Maria Repice; Lorenzo Emmi; Domenico Prisco; Vittorio Martinelli; Roberta Scotti; Niloufar Sadeghi; Gaetano Perrotta; Pascal Sati; Bernard Dachy; Daniel S Reich; Massimo Filippi; Luca Massacesi
Journal:  Ann Neurol       Date:  2018-02-15       Impact factor: 10.422

8.  Acute motor and sensory axonal neuropathy in association with primary Sjögren's syndrome: a case report.

Authors:  Yu-Ming Chen; Kuei-Ying Su
Journal:  BMC Neurol       Date:  2021-04-15       Impact factor: 2.474

Review 9.  Motor neuron disease in a patient with overlap syndrome (rheumatoid arthritis; systemic lupus erythematosus, Sjogren's syndrome).

Authors:  Ebru Atalar; Fatma Gül Yurdakul; Kevser Gök; Tuba Güler; Şükran Erten; Evren Yaşar; Hatice Bodur
Journal:  Rheumatol Int       Date:  2022-09-18       Impact factor: 3.580

Review 10.  Cholinergic anti-inflammatory pathway and connective tissue diseases.

Authors:  Khalil Hajiasgharzadeh; Alireza Khabbazi; Ahad Mokhtarzadeh; Amir Baghbanzadeh; Zahra Asadzadeh; Elham Adlravan; Behzad Baradaran
Journal:  Inflammopharmacology       Date:  2021-06-14       Impact factor: 4.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.